Abstract

Text messaging can promote healthy behaviors, like adherence to medication, yet its effectiveness remains modest, in part because message content is rarely personalized. Reinforcement learning has been used in consumer technology to personalize content but with limited application in healthcare. We tested a reinforcement learning program that identifies individual responsiveness (“adherence”) to text message content and personalizes messaging accordingly. We randomized 60 individuals with diabetes and glycated hemoglobin A1c [HbA1c] ≥ 7.5% to reinforcement learning intervention or control (no messages). Both arms received electronic pill bottles to measure adherence. The intervention improved absolute adjusted adherence by 13.6% (95%CI: 1.7%–27.1%) versus control and was more effective in patients with HbA1c 7.5- < 9.0% (36.6%, 95%CI: 25.1%–48.2%, interaction p < 0.001). We also explored whether individual patient characteristics were associated with differential response to tested behavioral factors and unique clusters of responsiveness. Reinforcement learning may be a promising approach to improve adherence and personalize communication at scale.

Details

Title
The impact of using reinforcement learning to personalize communication on medication adherence: findings from the REINFORCE trial
Author
Lauffenburger, Julie C. 1   VIAFID ORCID Logo  ; Yom-Tov, Elad 2 ; Keller, Punam A. 3 ; McDonnell, Marie E. 4 ; Crum, Katherine L. 1   VIAFID ORCID Logo  ; Bhatkhande, Gauri 1 ; Sears, Ellen S. 1 ; Hanken, Kaitlin 1 ; Bessette, Lily G. 1   VIAFID ORCID Logo  ; Fontanet, Constance P. 1 ; Haff, Nancy 1 ; Vine, Seanna 1 ; Choudhry, Niteesh K. 1 

 Brigham and Women’s Hospital and Harvard Medical School, Center for Healthcare Delivery Sciences, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294) 
 Microsoft Research, Herzliya, Israel (GRID:grid.62560.37) 
 Dartmouth College, Tuck School of Business, Hanover, USA (GRID:grid.254880.3) (ISNI:0000 0001 2179 2404) 
 Brigham and Women’s Hospital and Harvard Medical School, Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294) 
Pages
39
Publication year
2024
Publication date
Dec 2024
Publisher
Nature Publishing Group
e-ISSN
23986352
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2928443665
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.